title: Guidelines for the use of recombinant human erythropoietin.
authors.affiliation: Clinica Medica 2, IRCCS Policlinico S. Matteo, Pavia, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Barosi
authors.forename: M
authors.initials: M
authors.lastname: Cazzola
authors.forename: A
authors.initials: A
authors.lastname: De Vincentiis
authors.forename: A
authors.initials: A
authors.lastname: Grossi
authors.forename: S
authors.initials: S
authors.lastname: Tura
mesh_terms: D000740:Anemia / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D002986:Clinical Trials as Topic / Q000379:methods; D003362:Cost-Benefit Analysis; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D000090463:Iron Deficiencies; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D013163:Splenomegaly / Q000139:chemically induced
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin